{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T19:06:10Z","timestamp":1781118370661,"version":"3.54.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["K08CA266824"],"award-info":[{"award-number":["K08CA266824"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare cancer, and few studies have comprehensively investigated the immune microenvironment and rare lymphocyte-predominant (LP) cells. Here we develop a NLPHL specific lymphocyte-predominant ecotype (LPE) model to identify 34 distinct cell states across 14 cell types that co-occur within 3 LPEs for 171 cases. LPE1 and LPE2 were characterized by immunosuppressive microenvironments with high expression of <jats:italic>B2M<\/jats:italic> on LP cells, CD8 T-cell exhaustion, immune checkpoint genes expressed by follicular T-cells, and an improved freedom from progression compared to LPE3 in training (<jats:italic>n<\/jats:italic>\u2009=\u2009109, with 65% LPE1\/2) and validation cohorts (<jats:italic>n<\/jats:italic>\u2009=\u200962, with 61% LPE1\/2). We validate the co-occurrence and co-localization of cell states using spatial transcriptomics. Protein expression of HLA-I and HLA-II on LP cells and SSTR2 on dendritic cells was predictive of LPE1 (C-statistic=0.69), LPE2 (C-statistic=0.79), and LPE3 (C-statistic=0.60). This study establishes a clinically relevant biologic categorization for NLPHL.<\/jats:p>","DOI":"10.1038\/s41467-025-63339-9","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T12:09:42Z","timestamp":1758888582000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Distinct cell state ecosystems for nodular lymphocyte-predominant Hodgkin lymphoma"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7892-886X","authenticated-orcid":false,"given":"Ajay","family":"Subramanian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6946-8256","authenticated-orcid":false,"given":"Shengqin","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4182-9355","authenticated-orcid":false,"given":"Jamie","family":"Flerlage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6825-702X","authenticated-orcid":false,"given":"Stefan","family":"Alig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheren","family":"Younes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianna J.","family":"Marks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsea","family":"Pinnix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5956-452X","authenticated-orcid":false,"given":"Francisco","family":"Vega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8945-6917","authenticated-orcid":false,"given":"Priya","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Mocikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Sykorova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9861-3117","authenticated-orcid":false,"given":"Vit","family":"Prochazka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiane","family":"Milito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darina","family":"Paulino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Ramsay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Flerlage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2624-0868","authenticated-orcid":false,"given":"Monica","family":"Palese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ChunFang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0583-4584","authenticated-orcid":false,"given":"Troy","family":"Noordenbos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4128-2537","authenticated-orcid":false,"given":"Joseph","family":"Schroers-Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuchun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie J.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8692-1457","authenticated-orcid":false,"given":"Anusha","family":"Kalbasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7913-5351","authenticated-orcid":false,"given":"Everett J.","family":"Moding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1857-8172","authenticated-orcid":false,"given":"Aaron M.","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjana H.","family":"Advani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0125-0194","authenticated-orcid":false,"given":"Richard T.","family":"Hoppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2032-0581","authenticated-orcid":false,"given":"Maximilian","family":"Diehn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9816-1018","authenticated-orcid":false,"given":"Yasodha","family":"Natkunam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5153-5625","authenticated-orcid":false,"given":"Ash A.","family":"Alizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2640-5255","authenticated-orcid":false,"given":"Michael Sargent","family":"Binkley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"key":"63339_CR1","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow, S. H. et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127, 2375\u20132390 (2016).","journal-title":"Blood"},{"key":"63339_CR2","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.3390\/cancers13123021","volume":"13","author":"S Younes","year":"2021","unstructured":"Younes, S., Rojansky, R. B., Menke, J. R., Gratzinger, D. & Natkunam, Y. Pitfalls in the diagnosis of nodular lymphocyte predominant Hodgkin lymphoma: variant patterns, borderlines and mimics. Cancers 13, 3021 (2021).","journal-title":"Cancers"},{"key":"63339_CR3","doi-asserted-by":"publisher","unstructured":"Campo, E. et al. The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee. Blood. https:\/\/doi.org\/10.1182\/blood.2022015851 (2022).","DOI":"10.1182\/blood.2022015851"},{"key":"63339_CR4","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1056\/NEJM198801283180404","volume":"318","author":"DP Regula","year":"1988","unstructured":"Regula, D. P., Hoppe, R. T. & Weiss, L. M. Nodular and diffuse types of lymphocyte predominance Hodgkin\u2019s disease. N. Engl. J. Med 318, 214\u2013219 (1988).","journal-title":"N. Engl. J. Med"},{"key":"63339_CR5","doi-asserted-by":"publisher","unstructured":"Eichenauer, D. A. et al. Long-term follow-up of patients with nodular lymphocyte-predominant Hodgkin lymphoma treated in the HD7 to HD15 trials: a report from the German Hodgkin Study Group. J. Clin. Oncol. https:\/\/doi.org\/10.1200\/JCO.19.00986 (2019).","DOI":"10.1200\/JCO.19.00986"},{"key":"63339_CR6","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1055\/s-0035-1559664","volume":"227","author":"C Mauz-K\u00f6rholz","year":"2015","unstructured":"Mauz-K\u00f6rholz, C. et al. Pediatric nodular lymphocyte-predominant Hodgkin lymphoma: treatment recommendations of the GPOH-HD study group. Klin. Padiatr. 227, 314\u2013321 (2015).","journal-title":"Klin. Padiatr."},{"key":"63339_CR7","first-page":"1063","volume":"26","author":"RJ Lukes","year":"1966","unstructured":"Lukes, R. J. & Butler, J. J. The pathology and nomenclature of Hodgkin\u2019s disease. Cancer Res. 26, 1063\u20131083 (1966).","journal-title":"Cancer Res."},{"key":"63339_CR8","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1097\/00000478-200310000-00007","volume":"27","author":"Z Fan","year":"2003","unstructured":"Fan, Z., Natkunam, Y., Bair, E., Tibshirani, R. & Warnke, R. A. Characterization of variant patterns of nodular lymphocyte predominant hodgkin lymphoma with immunohistologic and clinical correlation. Am. J. Surg. Pathol. 27, 1346\u20131356 (2003).","journal-title":"Am. J. Surg. Pathol."},{"key":"63339_CR9","doi-asserted-by":"crossref","unstructured":"Hartmann, S. et al. Tumor cell characteristics and microenvironment composition correspond to clinical presentation in newly diagnosed nodular lymphocyte predominant Hodgkin lymphoma. Br. J. Haematol. 199, 382\u2013391 (2022).","DOI":"10.1111\/bjh.18376"},{"key":"63339_CR10","doi-asserted-by":"publisher","unstructured":"Binkley, M. S. & Advani, R. H. Treatment approaches for nodular lymphocyte-predominant Hodgkin lymphoma. Clin. Lymphoma Myeloma Leuk. S2152-2650(23)00111\u20138 https:\/\/doi.org\/10.1016\/j.clml.2023.03.014 (2023).","DOI":"10.1016\/j.clml.2023.03.014"},{"key":"63339_CR11","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1182\/blood.2019003877","volume":"135","author":"MS Binkley","year":"2020","unstructured":"Binkley, M. S. et al. Stage I-II nodular lymphocyte-predominant Hodgkin lymphoma: a multi-institutional study of adult patients by ILROG. Blood 135, 2365\u20132374 (2020).","journal-title":"Blood"},{"key":"63339_CR12","doi-asserted-by":"publisher","first-page":"4246","DOI":"10.1182\/blood-2013-07-515825","volume":"122","author":"S Hartmann","year":"2013","unstructured":"Hartmann, S. et al. The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG). Blood 122, 4246\u20134252 (2013).","journal-title":"Blood"},{"key":"63339_CR13","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1200\/JCO.23.01655","volume":"42","author":"MS Binkley","year":"2024","unstructured":"Binkley, M. S. et al. International prognostic score for nodular lymphocyte\u2013predominant hodgkin lymphoma. J. Clin. Oncol. 42, 2271\u20132280 (2024).","journal-title":"J. Clin. Oncol."},{"key":"63339_CR14","doi-asserted-by":"publisher","unstructured":"Aoki, T. et al. Single cell transcriptome analysis reveals disease-defining T cell subsets in the tumor microenvironment of classic Hodgkin lymphoma. Cancer Discov. https:\/\/doi.org\/10.1158\/2159-8290.CD-19-0680 (2019).","DOI":"10.1158\/2159-8290.CD-19-0680"},{"key":"63339_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110713","volume":"39","author":"X Ye","year":"2022","unstructured":"Ye, X. et al. A single-cell atlas of diffuse large B cell lymphoma. Cell Rep. 39, 110713 (2022).","journal-title":"Cell Rep."},{"key":"63339_CR16","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.cell.2021.01.010","volume":"184","author":"S Cheng","year":"2021","unstructured":"Cheng, S. et al. A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells. Cell 184, 792\u2013809.e23 (2021).","journal-title":"Cell"},{"key":"63339_CR17","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/s41586-021-03187-x","volume":"591","author":"J Merkenschlager","year":"2021","unstructured":"Merkenschlager, J. et al. Dynamic regulation of TFH selection during the germinal centre reaction. Nature 591, 458\u2013463 (2021).","journal-title":"Nature"},{"key":"63339_CR18","doi-asserted-by":"publisher","DOI":"10.1126\/science.abo0510","volume":"376","author":"C Suo","year":"2022","unstructured":"Suo, C. et al. Mapping the developing human immune system across organs. Science 376, eabo0510 (2022).","journal-title":"Science"},{"key":"63339_CR19","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","volume":"37","author":"AM Newman","year":"2019","unstructured":"Newman, A. M. et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat. Biotechnol. 37, 773\u2013782 (2019).","journal-title":"Nat. Biotechnol."},{"key":"63339_CR20","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1016\/j.ccell.2021.08.011","volume":"39","author":"CB Steen","year":"2021","unstructured":"Steen, C. B. et al. The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma. Cancer Cell 39, 1422\u20131437.e10 (2021).","journal-title":"Cancer Cell"},{"key":"63339_CR21","doi-asserted-by":"publisher","unstructured":"Lo, A. C. et al. Practice patterns for the management of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL): an international survey by the Global NLPHL One Working Group (GLOW). Leuk. Lymphoma 1\u20134. https:\/\/doi.org\/10.1080\/10428194.2022.2053533 (2022).","DOI":"10.1080\/10428194.2022.2053533"},{"key":"63339_CR22","first-page":"2343","volume":"141","author":"BJ Stewart","year":"2023","unstructured":"Stewart, B. J. et al. Spatial and molecular profiling of the mononuclear phagocyte network in classic Hodgkin lymphoma. Blood 141, 2343\u20132358 (2023).","journal-title":"Blood"},{"key":"63339_CR23","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1200\/JCO.2018.78.5246","volume":"36","author":"DM Kurtz","year":"2018","unstructured":"Kurtz, D. M. et al. Circulating tumor DNA measurements as early outcome predictors in diffuse large B-cell lymphoma. J. Clin. Oncol. 36, 2845\u20132853 (2018).","journal-title":"J. Clin. Oncol."},{"key":"63339_CR24","doi-asserted-by":"publisher","unstructured":"Alig, S. K. et al. Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling. Nature 1\u20133. https:\/\/doi.org\/10.1038\/s41586-023-06903-x (2023).","DOI":"10.1038\/s41586-023-06903-x"},{"key":"63339_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-024-01073-z","volume":"14","author":"S Younes","year":"2024","unstructured":"Younes, S. et al. Spatial phenotyping of nodular lymphocyte predominant Hodgkin lymphoma and T-cell\/histiocyte-rich large B-cell lymphoma. Blood Cancer J. 14, 92 (2024).","journal-title":"Blood Cancer J."},{"key":"63339_CR26","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1084\/jem.20080809","volume":"205","author":"V Brune","year":"2008","unstructured":"Brune, V. et al. Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis. J. Exp. Med. 205, 2251\u20132268 (2008).","journal-title":"J. Exp. Med."},{"key":"63339_CR27","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","volume":"36","author":"R Alaggio","year":"2022","unstructured":"Alaggio, R. et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia 36, 1720\u20131748 (2022).","journal-title":"Leukemia"},{"key":"63339_CR28","doi-asserted-by":"publisher","unstructured":"Natkunam, Y. et al. Spatial Phenotyping of Nodular Lymphocyte Predominant Hodgkin Lymphoma and T-Cell\/Histiocyte-Rich Large B-Cell Lymphoma. https:\/\/www.researchsquare.com\/article\/rs-3629195\/v1; https:\/\/doi.org\/10.21203\/rs.3.rs-3629195\/v1 (2023).","DOI":"10.21203\/rs.3.rs-3629195\/v1"},{"key":"63339_CR29","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbac430","volume":"23","author":"J Fan","year":"2022","unstructured":"Fan, J. et al. MuSiC2: cell-type deconvolution for multi-condition bulk RNA-seq data. Brief. Bioinform 23, bbac430 (2022).","journal-title":"Brief. Bioinform"},{"key":"63339_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10802-z","volume":"10","author":"D Tsoucas","year":"2019","unstructured":"Tsoucas, D. et al. Accurate estimation of cell-type composition from gene expression data. Nat. Commun. 10, 2975 (2019).","journal-title":"Nat. Commun."},{"key":"63339_CR31","doi-asserted-by":"publisher","first-page":"330","DOI":"10.3324\/haematol.2018.203224","volume":"104","author":"B Schuhmacher","year":"2019","unstructured":"Schuhmacher, B. et al. JUNB, DUSP2, SGK1, SOCS1 and CREBBP are frequently mutated in T-cell\/histiocyte-rich large B-cell lymphoma. Haematologica 104, 330\u2013337 (2019).","journal-title":"Haematologica"},{"key":"63339_CR32","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/leu.2015.328","volume":"30","author":"S Hartmann","year":"2016","unstructured":"Hartmann, S. et al. Highly recurrent mutations of SGK1, DUSP2 and JUNB in nodular lymphocyte predominant Hodgkin lymphoma. Leukemia 30, 844\u2013853 (2016).","journal-title":"Leukemia"},{"key":"63339_CR33","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1101\/gr.234807.118","volume":"29","author":"JW Foley","year":"2019","unstructured":"Foley, J. W. et al. Gene expression profiling of single cells from archival tissue with laser-capture microdissection and Smart-3SEQ. Genome Res. 29, 1816\u20131825 (2019).","journal-title":"Genome Res."},{"key":"63339_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1842-9","volume":"20","author":"BJ Haas","year":"2019","unstructured":"Haas, B. J. et al. Accuracy assessment of fusion transcript detection via read-mapping and de novo fusion transcript assembly-based methods. Genome Biol. 20, 213 (2019).","journal-title":"Genome Biol."},{"key":"63339_CR35","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/0008-8749(90)90260-X","volume":"131","author":"DM Baume","year":"1990","unstructured":"Baume, D. M., Caligiuri, M. A., Manley, T. J., Daley, J. F. & Ritz, J. Differential expression of CD8 alpha and CD8 beta associated with MHC-restricted and non-MHC-restricted cytolytic effector cells. Cell Immunol. 131, 352\u2013365 (1990).","journal-title":"Cell Immunol."},{"key":"63339_CR36","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1158\/0008-5472.CAN-20-3510","volume":"81","author":"S Tartey","year":"2021","unstructured":"Tartey, S., Neale, G., Vogel, P., Malireddi, R. K. S. & Kanneganti, T.-D. A MyD88\/IL1R axis regulates PD-1 expression on tumor-associated macrophages and sustains their immunosuppressive function in melanoma. Cancer Res. 81, 2358\u20132372 (2021).","journal-title":"Cancer Res."},{"key":"63339_CR37","doi-asserted-by":"publisher","first-page":"3837","DOI":"10.1073\/pnas.0712250105","volume":"105","author":"M Griffioen","year":"2008","unstructured":"Griffioen, M. et al. Identification of phosphatidylinositol 4-kinase type II beta as HLA class II-restricted target in graft versus leukemia reactivity. Proc. Natl Acad. Sci. USA 105, 3837\u20133842 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"63339_CR38","doi-asserted-by":"crossref","unstructured":"Machy, P., Mortier, E. & Birkl\u00e9, S. Biology of GD2 ganglioside: implications for cancer immunotherapy. Front. Pharmacol. 14, 1249929 (2023).","DOI":"10.3389\/fphar.2023.1249929"},{"key":"63339_CR39","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20200483","volume":"217","author":"AB Holmes","year":"2020","unstructured":"Holmes, A. B. et al. Single-cell analysis of germinal-center B cells informs on lymphoma cell of origin and outcome. J. Exp. Med. 217, e20200483 (2020).","journal-title":"J. Exp. Med."},{"key":"63339_CR40","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.immuni.2019.01.001","volume":"50","author":"RJ Miragaia","year":"2019","unstructured":"Miragaia, R. J. et al. Single-cell transcriptomics of regulatory T cells reveals trajectories of tissue adaptation. Immunity 50, 493\u2013504.e7 (2019).","journal-title":"Immunity"},{"key":"63339_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24213-6","volume":"12","author":"Y Luo","year":"2021","unstructured":"Luo, Y. et al. Single-cell transcriptomic analysis reveals disparate effector differentiation pathways in human Treg compartment. Nat. Commun. 12, 3913 (2021).","journal-title":"Nat. Commun."},{"key":"63339_CR42","doi-asserted-by":"publisher","DOI":"10.1126\/science.abe6474","volume":"374","author":"L Zheng","year":"2021","unstructured":"Zheng, L. et al. Pan-cancer single-cell landscape of tumor-infiltrating T cells. Science 374, abe6474 (2021).","journal-title":"Science"},{"key":"63339_CR43","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1158\/2326-6066.CIR-16-0201","volume":"4","author":"MGM Roemer","year":"2016","unstructured":"Roemer, M. G. M. et al. Classical Hodgkin lymphoma with reduced \u03b22M\/MHC class I expression is associated with inferior outcome independent of 9p24.1 status. Cancer Immunol. Res. 4, 910\u2013916 (2016).","journal-title":"Cancer Immunol. Res."},{"key":"63339_CR44","doi-asserted-by":"publisher","unstructured":"Boen, J., Wagner, J. P. & Di Nanni, N. Inferring Copy Number Variation from Gene Expression Data: Methods, Comparisons, and Applications to Oncology. http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2021.10.18.463991; https:\/\/doi.org\/10.1101\/2021.10.18.463991 (2021).","DOI":"10.1101\/2021.10.18.463991"},{"key":"63339_CR45","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.3324\/haematol.2022.280014","volume":"108","author":"JG Taylor","year":"2022","unstructured":"Taylor, J. G., Truelove, E., Clear, A., Calaminici, M. & Gribben, J. G. PDL1 shapes the classical Hodgkin lymphoma microenvironment without inducing T-cell exhaustion. Haematologica 108, 1068\u20131082 (2022).","journal-title":"Haematologica"},{"key":"63339_CR46","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1200\/JCO.2013.53.2069","volume":"32","author":"RH Advani","year":"2014","unstructured":"Advani, R. H. et al. Mature results of a phase II study of rituximab therapy for nodular lymphocyte-predominant Hodgkin lymphoma. J. Clin. Oncol. 32, 912\u2013918 (2014).","journal-title":"J. Clin. Oncol."},{"key":"63339_CR47","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/s41592-021-01142-2","volume":"18","author":"L Song","year":"2021","unstructured":"Song, L. et al. TRUST4: immune repertoire reconstruction from bulk and single-cell RNA-seq data. Nat. Methods 18, 627\u2013630 (2021).","journal-title":"Nat. Methods"},{"key":"63339_CR48","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/nature22976","volume":"547","author":"J Glanville","year":"2017","unstructured":"Glanville, J. et al. Identifying specificity groups in the T cell receptor repertoire. Nature 547, 94\u201398 (2017).","journal-title":"Nature"},{"key":"63339_CR49","doi-asserted-by":"publisher","unstructured":"Thurner, L. et al. B-cell receptor reactivity against Rothia mucilaginosa in nodular lymphocyte-predominant Hodgkin lymphoma. Haematologica. https:\/\/doi.org\/10.3324\/haematol.2023.282698 (2023).","DOI":"10.3324\/haematol.2023.282698"},{"key":"63339_CR50","doi-asserted-by":"publisher","unstructured":"Zhang, X.-Y. & Collins, G. P. Checkpoint inhibitors and the changing face of the relapsed\/refractory classical Hodgkin lymphoma pathway. Curr. Oncol. Rep. https:\/\/doi.org\/10.1007\/s11912-022-01292-2 (2022).","DOI":"10.1007\/s11912-022-01292-2"},{"key":"63339_CR51","doi-asserted-by":"publisher","first-page":"364ra155","DOI":"10.1126\/scitranslmed.aai8545","volume":"8","author":"F Scherer","year":"2016","unstructured":"Scherer, F. et al. Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA. Sci. Transl. Med 8, 364ra155 (2016).","journal-title":"Sci. Transl. Med"},{"key":"63339_CR52","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3324\/haematol.2014.113472","volume":"100","author":"S Riihij\u00e4rvi","year":"2015","unstructured":"Riihij\u00e4rvi, S. et al. Prognostic influence of macrophages in patients with diffuse large B-cell lymphoma: a correlative study from a Nordic phase II trial. Haematologica 100, 238\u2013245 (2015).","journal-title":"Haematologica"},{"key":"63339_CR53","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1182\/blood-2023-187038","volume":"142","author":"J Paczkowska","year":"2023","unstructured":"Paczkowska, J. et al. Single-cell RNA sequencing reveals the interplay between circulating CD4 + T cells, B cells and cancer-associated monocytes in classic Hodgkin lymphoma treated with PD-1 blockade. Blood 142, 173 (2023).","journal-title":"Blood"},{"key":"63339_CR54","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/hon.3163_62","volume":"41","author":"MS Binkley","year":"2023","unstructured":"Binkley, M. S. et al. The prognostic impact of clinical factors and immunoarchitectural patterns for nodular lymphocyte-predominant Hodgkin lymphoma: an international study by glow. Hematol. Oncol. 41, 100\u2013101 (2023).","journal-title":"Hematol. Oncol."},{"key":"63339_CR55","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nmeth.4197","volume":"14","author":"R Patro","year":"2017","unstructured":"Patro, R., Duggal, G., Love, M. I., Irizarry, R. A. & Kingsford, C. Salmon: fast and bias-aware quantification of transcript expression using dual-phase inference. Nat. Methods 14, 417\u2013419 (2017).","journal-title":"Nat. Methods"},{"key":"63339_CR56","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman, A. M. et al. Robust enumeration of cell subsets from tissue expression profiles. Nat. Methods 12, 453\u2013457 (2015).","journal-title":"Nat. Methods"},{"key":"63339_CR57","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nbt.4096","volume":"36","author":"A Butler","year":"2018","unstructured":"Butler, A., Hoffman, P., Smibert, P., Papalexi, E. & Satija, R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36, 411\u2013420 (2018).","journal-title":"Nat. Biotechnol."},{"key":"63339_CR58","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart, T. et al. Comprehensive integration of single-cell data. Cell 177, 1888\u20131902.e21 (2019).","journal-title":"Cell"},{"key":"63339_CR59","doi-asserted-by":"publisher","first-page":"eabl5197","DOI":"10.1126\/science.abl5197","volume":"376","author":"C Dom\u00ednguez Conde","year":"2022","unstructured":"Dom\u00ednguez Conde, C. et al. Cross-tissue immune cell analysis reveals tissue-specific features in humans. Science 376, eabl5197 (2022).","journal-title":"Science"},{"key":"63339_CR60","doi-asserted-by":"publisher","first-page":"5482","DOI":"10.1016\/j.cell.2021.09.014","volume":"184","author":"BA Luca","year":"2021","unstructured":"Luca, B. A. et al. Atlas of clinically distinct cell states and ecosystems across human solid tumors. Cell 184, 5482\u20135496.e28 (2021).","journal-title":"Cell"},{"key":"63339_CR61","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/biomet\/37.1-2.17","volume":"37","author":"PAP Moran","year":"1950","unstructured":"Moran, P. A. P. Notes on continuous stochastic phenomena. Biometrika 37, 17\u201323 (1950).","journal-title":"Biometrika"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-63339-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-63339-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-63339-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T13:04:23Z","timestamp":1758891863000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-63339-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["63339"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-63339-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"18 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"H.M. reports consulting and honoraria with Lilly, Bristol-Myers Squibb, Abbvie, and Roche. M.D. reports research funding from AstraZeneca, Genentech, Varian Medical Systems and Illumina, ownership interest in CiberMed and Foresight Diagnostics, consultancy from AstraZeneca, Boehringer Ingelheim, BMS, Genentech, Gritstone Oncology, Illumina, Regeneron and Roche, and multiple issued and pending patents including patents licensed to Foresight Diagnostics and Roche. A.A.A. reports consultancy for Celgene, Chugai, Genentech, Gilead, Janssen, Pharmacyclics and Roche, scientific advisory board membership in the Lymphoma Research Foundation, and Professional Affiliations with the American Society of Hematology, American Society of Clinical Oncology, American Society of Clinical Investigation, Leukemia & Lymphoma Society, Research Funding from the National Cancer Institute, the National Heart, Lung, and Blood Institute, the US National Institutes of Health, Celgene, BMS and Pfizer, patent filings including patent issued, licensed and with royalties paid from FortySeven, a patent pending and Licensed to Foresight, a patent pending relating to MARIA, a patent issued and licensed to CiberMed, a patent issued and a patent pending to CiberMed, patents issued to Idiotype Vaccines, and a patent issued, licensed and with royalties paid from Roche, and equity ownership interests in CiberMed Inc., ForeSight Diagnostics, FortySeven Inc. and CARGO Therapeutics. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8473"}}